Order Article Reprints

Mizielska A, Dziechciowska I, Szczepański R, Cisek M, Dąbrowska M, Ślężak J, Kosmalska I, Rymarczyk M, Wilkowska K, Jacczak B, et al. Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells—A Preliminary Study. Genes. 2023; 14(3):702. https://doi.org/10.3390/genes14030702

Mizielska, Anna, Iga Dziechciowska, Radosław Szczepański, Małgorzata Cisek, Małgorzata Dąbrowska, Jan Ślężak, Izabela Kosmalska, Marta Rymarczyk, Klaudia Wilkowska, Barbara Jacczak, and et al. 2023. "Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells—A Preliminary Study" Genes 14, no. 3: 702. https://doi.org/10.3390/genes14030702

Mizielska, A., Dziechciowska, I., Szczepański, R., Cisek, M., Dąbrowska, M., Ślężak, J., Kosmalska, I., Rymarczyk, M., Wilkowska, K., Jacczak, B., Totoń, E., Lisiak, N., Kopczyński, P., & Rubiś, B. (2023). Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells—A Preliminary Study. Genes, 14(3), 702. https://doi.org/10.3390/genes14030702